Elecsys Amyloid Plasma Panel

Elecsys Amyloid Plasma Panel (EAPP) is a multicenter, prospective, non-interventional study aimed at demonstrating the clinical performance of the EAPP test, a test to facilitate the early diagnosis of Alzheimer's disease. This tool would make it possible to identify the likelihood of amyloid pathology in people with subjective memory complaints from a blood test, and to determine whether they should undergo further evaluation and testing that could confirm the diagnosis. In this clinical trial, people aged 55 to 80 years with subjective memory complaints or mild cognitive impairment are participating.